Weichenhan D - Search Results

1

Calcification of myocardial necrosis is common in mice.

Korff S, Riechert N, Schoensiegel F, Weichenhan D, Autschbach F, Katus HA, Ivandic BT. Korff S, et al. Among authors: weichenhan d. Virchows Arch. 2006 May;448(5):630-8. doi: 10.1007/s00428-005-0071-7. Epub 2005 Oct 7. Virchows Arch. 2006. PMID: 16211391

2

A locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice.

Aherrahrou Z, Axtner SB, Kaczmarek PM, Jurat A, Korff S, Doehring LC, Weichenhan D, Katus HA, Ivandic BT. Aherrahrou Z, et al. Among authors: weichenhan d. Am J Pathol. 2004 Apr;164(4):1379-87. doi: 10.1016/S0002-9440(10)63224-5. Am J Pathol. 2004. PMID: 15039225 Free PMC article.

3

S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts.

Remppis A, Pleger ST, Most P, Lindenkamp J, Ehlermann P, Schweda C, Löffler E, Weichenhan D, Zimmermann W, Eschenhagen T, Koch WJ, Katus HA. Remppis A, et al. Among authors: weichenhan d. J Gene Med. 2004 Apr;6(4):387-94. doi: 10.1002/jgm.513. J Gene Med. 2004. PMID: 15079813

4

S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.

Pleger ST, Remppis A, Heidt B, Völkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Müller OJ, Eckhart AD, Katus HA, Koch WJ, Most P. Pleger ST, et al. Among authors: weichenhan d. Mol Ther. 2005 Dec;12(6):1120-9. doi: 10.1016/j.ymthe.2005.08.002. Epub 2005 Sep 15. Mol Ther. 2005. PMID: 16168714 Free article.

5

Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.

Ehlermann P, Eggers K, Bierhaus A, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, Remppis A. Ehlermann P, et al. Among authors: weichenhan d. Cardiovasc Diabetol. 2006 Mar 30;5:6. doi: 10.1186/1475-2840-5-6. Cardiovasc Diabetol. 2006. PMID: 16573830 Free PMC article.

6

Early diagnostic marker panel determination for microarray based clinical studies.

Jaeger J, Weichenhan D, Ivandic B, Spang R. Jaeger J, et al. Among authors: weichenhan d. Stat Appl Genet Mol Biol. 2005;4:Article9. doi: 10.2202/1544-6115.1109. Epub 2005 Apr 26. Stat Appl Genet Mol Biol. 2005. PMID: 16646862

7

Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice.

Korff S, Schoensiegel F, Riechert N, Weichenhan D, Katus HA, Ivandic BT. Korff S, et al. Among authors: weichenhan d. Physiol Genomics. 2006 May 16;25(3):387-92. doi: 10.1152/physiolgenomics.00010.2006. Physiol Genomics. 2006. PMID: 16705021

8

Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE.

Zeller R, Ivandic BT, Ehlermann P, Mücke O, Zugck C, Remppis A, Giannitsis E, Katus HA, Weichenhan D. Zeller R, et al. Among authors: weichenhan d. J Mol Med (Berl). 2006 Aug;84(8):682-91. doi: 10.1007/s00109-006-0056-2. Epub 2006 May 20. J Mol Med (Berl). 2006. PMID: 16715312

9

Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.

Geiger SK, Bär H, Ehlermann P, Wälde S, Rutschow D, Zeller R, Ivandic BT, Zentgraf H, Katus HA, Herrmann H, Weichenhan D. Geiger SK, et al. Among authors: weichenhan d. J Mol Med (Berl). 2008 Mar;86(3):281-9. doi: 10.1007/s00109-007-0275-1. Epub 2007 Nov 7. J Mol Med (Berl). 2008. PMID: 17987279

10

Atrial natriuretic peptide and osteopontin are useful markers of cardiac disorders in mice.

Schoensiegel F, Bekeredjian R, Schrewe A, Weichenhan D, Frey N, Katus HA, Ivandic BT. Schoensiegel F, et al. Among authors: weichenhan d. Comp Med. 2007 Dec;57(6):546-53. Comp Med. 2007. PMID: 18246866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters